The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Polymeric nanoparticles for targeted treatment in oncology: current insights
Open accessAbstract
Chemotherapy, a major strategy for cancer treatment, lacks the specificity to localize the cancer therapeutics in the tumor site, thereby affecting normal healthy tissues and advocating toxic adverse effects. Nanotechnological intervention has greatly revolutionized the therapy of cancer by surmounting the current limitations in conventional chemotherapy, which include undesirable biodistribution, cancer cell drug resistance, and severe systemic side effects. Nanoparticles (NPs) achieve preferential accumulation in the tumor site by virtue of their passive and ligand-based targeting mechanisms. Polymer-based nanomedicine, an arena that entails the use of polymeric NPs, polymer micelles, dendrimers, polymersomes, polyplexes, polymer-lipid hybrid systems, and polymer-drug/protein conjugates for improvement in efficacy of cancer therapeutics, has been widely explored. The broad scope for chemically modifying the polymer into desired construct makes it a versatile delivery system. Several polymer-based therapeutic NPs have been approved for clinical use. This review provides an insight into the advances in polymer-based targeted nanocarriers with focus on therapeutic aspects in the field of oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Matrix metalloproteinases and tumor metastasis
Deryugina, E. I., & Quigley, J. P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7886-9 · Cited by 1,960
VEGF as a Key Mediator of Angiogenesis in Cancer
Carmeliet, P. (2005) · Oncology · doi:10.1159/000088478 · Cited by 1,768
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Osborn, L., Hession, C., Tizard, R., Vassallo, C., Luhowskyj, S., Chi-Rosso, G., & Lobb, R. (1989) · Cell · doi:10.1016/0092-8674(89)90775-7 · Cited by 1,689
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Nanoparticle Delivery of Cancer Drugs
Wang, A. Z., Langer, R., & Farokhzad, O. C. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-040210-162544 · Cited by 1,561
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
Targeted drug delivery via the folate receptor
Sudimack, J., & Lee, R. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00062-9 · Cited by 1,474
Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Hrkach, J., Von Hoff, D., Ali, M. M., Andrianova, E., Auer, J., Campbell, T., De Witt, D., Figa, M., Figueiredo, M., Horhota, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003651 · Cited by 1,147
Letchford, K., & Burt, H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.009 · Cited by 1,143
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., & Maitra, A. (2007) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-5-3 · Cited by 1,090
Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
Zhang, L., Chan, J. M., Gu, F. X., Rhee, J.-W., Wang, A. Z., Radovic-Moreno, A. F., Alexis, F., Langer, R., & Farokhzad, O. C. (2008) · ACS Nano · doi:10.1021/nn800275r · Cited by 1,038
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Davis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 977
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Oerlemans, C., Bult, W., Bos, M., Storm, G., Nijsen, J. F. W., & Hennink, W. E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0233-4 · Cited by 947
The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy
Scaltriti, M., & Baselga, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1554 · Cited by 913
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Sinha, R., Kim, G. J., Nie, S., & Shin, D. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0141 · Cited by 801
Nanoparticles for drug delivery in cancer treatment
Haley, B., & Frenkel, E. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.015 · Cited by 791
Surface-Charge-Dependent Cell Localization and Cytotoxicity of Cerium Oxide Nanoparticles
Asati, A., Santra, S., Kaittanis, C., & Perez, J. M. (2010) · ACS Nano · doi:10.1021/nn100816s · Cited by 701
Folate receptor targeted biodegradable polymeric doxorubicin micelles
Yoo, H. S., & Park, T. G. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.003 · Cited by 620
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.086 · Cited by 616
Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
Nishiyama, N., Okazaki, S., Cabral, H., Miyamoto, M., Kato, Y., Sugiyama, Y., Nishio, K., Matsumura, Y., & Kataoka, K. (2003) · PubMed · Cited by 604
PATRI, A., KUKOWSKALATALLO, J., & BAKERJR, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.014 · Cited by 597
Majoros, I. J., Myc, A., Thomas, T., Mehta, C. B., & Baker, J. R. (2006) · Biomacromolecules · doi:10.1021/bm0506142 · Cited by 596
Nanooncology: The future of cancer diagnosis and therapy
Thakor, A. S., & Gambhir, S. S. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21199 · Cited by 588
Folate-targeted therapeutic and imaging agents for cancer
Low, P. S., & Kularatne, S. A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.022 · Cited by 585
Functionalized micellar systems for cancer targeted drug delivery
Sutton, D., Nasongkla, N., Blanco, E., & Gao, J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9223-y · Cited by 557
Ahmed, F., Pakunlu, R. I., Brannan, A., Bates, F., Minko, T., & Discher, D. E. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.012 · Cited by 548
Tumour-targeted nanomedicines: principles and practice
Lammers, T., Hennink, W. E., & Storm, G. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604483 · Cited by 542
Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs
Torchilin, V. P., Lukyanov, A. N., Gao, Z., & Papahadjopoulos-Sternberg, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931428100 · Cited by 538
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Daniels, T. R., Delgado, T., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.006 · Cited by 518
Dhar, S., Kolishetti, N., Lippard, S. J., & Farokhzad, O. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011379108 · Cited by 513
Polyester Dendritic Systems for Drug Delivery Applications: In Vitro and In Vivo Evaluation
Padilla De Jesús, O. L., Ihre, H. R., Gagne, L., Fréchet, J. M. J., & Szoka, F. C. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010103m · Cited by 507
Targeted therapy using nanotechnology: focus on cancer
Sechi, M., Sanna, V., & Pala, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s36654 · Cited by 493
Increased exposure of anionic phospholipids on the surface of tumor blood vessels.
Ran, S., Downes, A., & Thorpe, P. E. (2002) · PubMed · Cited by 471
EGFR Signaling and Drug Discovery
Lurje, G., & Lenz, H.-J. (2009) · Oncology · doi:10.1159/000279388 · Cited by 442
cRGD‐Functionalized Polymer Micelles for Targeted Doxorubicin Delivery
Nasongkla, N., Shuai, X., Ai, H., Weinberg, B. D., Pink, J., Boothman, D. A., & Gao, J. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200460800 · Cited by 434
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Dendrimer-platinate: a novel approach to cancer chemotherapy.
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · PubMed · Cited by 417
p H-Sensitive Liposomes: Possible Clinical Implications
Yatvin, M. B., Kreutz, W., Horwitz, B. A., & Shinitzky, M. (1980) · Science · doi:10.1126/science.7434025 · Cited by 415
Targeted Nanoparticles for Cancer Therapy
Reddy, G. S. N. (2021) · Journal of Bioanalysis & Biomedicine · Cited by 401
Multifunctional Nanoparticles for Combined Doxorubicin and Photothermal Treatments
Park, H., Yang, J., Lee, J., Haam, S., Choi, I.-H., & Yoo, K.-H. (2009) · ACS Nano · doi:10.1021/nn900215k · Cited by 359
Transferrin-Containing, Cyclodextrin Polymer-Based Particles for Tumor-Targeted Gene Delivery
Bellocq, N. C., Pun, S. H., Jensen, G. S., & Davis, M. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034125f · Cited by 350
Wong, H. L., Bendayan, R., Rauth, A. M., Xue, H. Y., Babakhanian, K., & Wu, X. Y. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101154 · Cited by 344
Liu, Y., Li, K., Pan, J., Liu, B., & Feng, S.-S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.036 · Cited by 342
Polymeric Nanoparticles for Drug Delivery
Chan, J. M., Valencia, P. M., Zhang, L., Langer, R., & Farokhzad, O. C. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-609-2_11 · Cited by 339
Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
Acharya, S., Dilnawaz, F., & Sahoo, S. K. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.008 · Cited by 333
Ahmed, F., Pakunlu, R. I., Srinivas, G., Brannan, A., Bates, F., Klein, M. L., Minko, T., & Discher, D. E. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050103u · Cited by 330
αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
Graf, N., Bielenberg, D. R., Kolishetti, N., Muus, C., Banyard, J., Farokhzad, O. C., & Lippard, S. J. (2012) · ACS Nano · doi:10.1021/nn301148e · Cited by 327
Wang, F., Bronich, T. K., Kabanov, A. V., Rauh, R. D., & Roovers, J. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049784m · Cited by 317
Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels
Krasnici, S., Werner, A., Eichhorn, M. E., Schmitt‐Sody, M., Pahernik, S. A., Sauer, B., Schulze, B., Teifel, M., Michaelis, U., Naujoks, K., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11108 · Cited by 313
Folate receptor-targeted drugs for cancer and inflammatory diseases
Low, P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.003 · Cited by 306
Wong, H. L., Rauth, A. M., Bendayan, R., Manias, J. L., Ramaswamy, M., Liu, Z., Erhan, S. Z., & Wu, X. Y. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0282-x · Cited by 303
Morgan, M. T., Nakanishi, Y., Kroll, D. J., Griset, A. P., Carnahan, M. A., Wathier, M., Oberlies, N. H., Manikumar, G., Wani, M. C., & Grinstaff, M. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2066 · Cited by 301
Matrix Metalloproteinases as Therapeutic Targets in Cancer
Vihinen, P., Ala-aho, R., & Kahari, V.-M. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053765799 · Cited by 277
Park, E. K., Lee, S. B., & Lee, Y. M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.04.008 · Cited by 264
Differences between the Electrical Charge carried by Normal and Homologous Tumour Cells
AMBROSE, E. J., JAMES, A. M., & LOWICK, J. H. B. (1956) · Nature · doi:10.1038/177576a0 · Cited by 258
In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
de Menezes, D. E. L., Pilarski, L. M., & Allen, T. M. (1998) · PubMed · Cited by 257
Epidermal growth factor receptor: a promising target in solid tumours
Laskin, J. J., & Sandler, A. B. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.10.002 · Cited by 253
Dendritic Molecular Capsules for Hydrophobic Compounds
Morgan, M. T., Carnahan, M. A., Immoos, C. E., Ribeiro, A. A., Finkelstein, S., Lee, S. J., & Grinstaff, M. W. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0347383 · Cited by 252
Betancourt, T., Brown, B., & Brannon-Peppas, L. (2007) · Nanomedicine · doi:10.2217/17435889.2.2.219 · Cited by 249
Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers.
Bharali, D. J., Khalil, M., Gurbuz, M., et al. (2009) · PubMed · Cited by 238
Pastorino, F., Brignole, C., Di Paolo, D., Nico, B., Pezzolo, A., Marimpietri, D., Pagnan, G., Piccardi, F., Cilli, M., Longhi, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2117 · Cited by 232
Jain, A. K., Swarnakar, N. K., Godugu, C., Singh, R. P., & Jain, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.037 · Cited by 232
Wang, Y., Yu, L., Han, L., Sha, X., & Fang, X. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.033 · Cited by 226
Drug targeting to the colon with lectins and neoglycoconjugates
Minko, T. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.017 · Cited by 222
Iinuma, H., Maruyama, K., Okinaga, K., Sasaki, K., Sekine, T., Ishida, O., Ogiwara, N., Johkura, K., & Yonemura, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10242 · Cited by 216
Polymersomes: A new multi-functional tool for cancer diagnosis and therapy
Levine, D. H., Ghoroghchian, P. P., Freudenberg, J., Zhang, G., Therien, M. J., Greene, M. I., Hammer, D. A., & Murali, R. (2008) · Methods · doi:10.1016/j.ymeth.2008.05.006 · Cited by 216
Hu, C.-M. J., Kaushal, S., Cao, H. S. T., Aryal, S., Sartor, M., Esener, S., Bouvet, M., & Zhang, L. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900316a · Cited by 212
Mansour, A. M., Drevs, J., Esser, N., Hamada, F. M. A., Badary, O. A., Unger, C., Fichtner, I., & Kratz, F. (2003) · PubMed · Cited by 197
ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells
Chittasupho, C., Xie, S.-X., Baoum, A., Yakovleva, T., Siahaan, T. J., & Berkland, C. J. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.008 · Cited by 181
Clinical Developments in Nanotechnology for Cancer Therapy
Heidel, J. D., & Davis, M. E. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0178-7 · Cited by 170
Selective targeting of cancer cells using synthetic peptides
Shadidi, M., & Sioud, M. (2003) · Drug Resistance Updates · doi:10.1016/j.drup.2003.11.002 · Cited by 170
Wohlfart, S., Khalansky, A. S., Gelperina, S., Maksimenko, O., Bernreuther, C., Glatzel, M., & Kreuter, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019121 · Cited by 162
Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers
Mousa, S., Bharali, D., Khalil, M., Gurbuz, M., & Simone (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4241 · Cited by 162
Kobayashi, T., Ishida, T., Okada, Y., Ise, S., Harashima, H., & Kiwada, H. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.039 · Cited by 153
Emerging Technologies of Polymeric Nanoparticles in Cancer Drug Delivery
Brewer, E. C., Coleman, J., & Lowman, A. M. (2010) · Journal of Nanomaterials · doi:10.1155/2011/408675 · Cited by 145
Kumar, G. V., Nair, L., Jagadeeshan, S., & Nair, S. A. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s20165 · Cited by 143
MT1-MMP: Universal or particular player in angiogenesis?
Genı́s, L., Gálvez, B. G., Gonzalo, P., & Arroyo, A. G. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7891-z · Cited by 141
Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells
Gryparis, E. C., Hatziapostolou, M., Papadimitriou, Ε., & Avgoustakis, K. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.12.017 · Cited by 139
JEONG, Y., SEO, S., Park, I., Lee, H., Kang, I., Akaike, T., & CHO, C. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.027 · Cited by 138
Xu, J., Zhao, Q., Jin, Y., & Qiu, L. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.08.004 · Cited by 133
Self-Assembled Poly(butadiene)-b-poly(ethylene oxide) Polymersomes as Paclitaxel Carriers
Li, S., Byrne, B., Welsh, J., & Palmer, A. F. (2006) · Biotechnology Progress · doi:10.1021/bp060208 · Cited by 131
Nanosized Multifunctional Polyplexes for Receptor-Mediated SiRNA Delivery
Dohmen, C., Edinger, D., Fröhlich, T., Schreiner, L., Lächelt, U., Troiber, C., Rädler, J. O., Hadwiger, P., Vornlocher, H., & Wagner, E. (2012) · ACS Nano · doi:10.1021/nn300960m · Cited by 129
Devalapally, H., Duan, Z., Seiden, M. V., & Amiji, M. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4973 · Cited by 121
Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes
van Steenis, J. H., van Maarseveen, E. M., Verbaan, F. J., Verrijk, R., Crommelin, D. J. A., Storm, G., & Hennink, W. E. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00361-9 · Cited by 118
Surfactant–Polymer Nanoparticles Overcome P-Glycoprotein-Mediated Drug Efflux
Chavanpatil, M. D., Khdair, A., Gérard, B., Bachmeier, C. J., Miller, D. W., Shekhar, M. P. V., & Panyam, J. (2007) · Molecular Pharmaceutics · doi:10.1021/mp070024d · Cited by 117
Pharmacokinetic characteristics and anticancer effects of 5-Fluorouracil loaded nanoparticles
Li, S., Wang, A., Jiang, W., & Guan, Z. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-103 · Cited by 112
Wong, H. L., Rauth, A. M., Bendayan, R., & Wu, X. Y. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.022 · Cited by 109
Dual-targeted polyplexes: One step towards a synthetic virus for cancer gene therapy
Nie, Y., Schaffert, D., Rödl, W., Ogris, M., Wagner, E., & Günther, M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.028 · Cited by 106
Reduction of Drug Toxicity Using Dendrimers Based on Melamine
Neerman, M. F., Chen, H., Parrish, A. R., & Simanek, E. E. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049957p · Cited by 106
cRGD‐Functionalized Polymer Micelles for Targeted Doxorubicin Delivery
Nasongkla, N., Shuai, X., Ai, H., Weinberg, B. D., Pink, J. J., Boothman, D. A., & Gao, J. (2004) · Angewandte Chemie · doi:10.1002/ange.200460800 · Cited by 105
Boyer, C. A., Teo, J., Phillips, P. A., Erlich, R. B., Sagnella, S. M., Sharbeen, G., Dwarte, T. M., Duong, H. T. T., Goldstein, D., Davis, T. P., et al. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400049e · Cited by 102
Beh, C. W., Seow, W. Y., Wang, Y., Zhang, Y., Ong, Z. Y., Ee, P. L. R., & Yang, Y. Y. (2008) · Biomacromolecules · doi:10.1021/bm801109g · Cited by 97
Han, X. F., Liu, J., Liu, M., Xie, C., Zhan, C., Gu, B., Liu, Y., Feng, L., & Lu, W. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.035 · Cited by 97
Cheng, F., Su, C., Wu, P., et al. (2010) · Chemical Communications · doi:10.1039/b919172k · Cited by 96
Jeong, Y., & Kang, D. H. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s19491 · Cited by 96
Upadhyay, K. K., Mishra, A. K., Chuttani, K., Kaul, A., Schatz, C., Meins, J. L., Misra, A. R., & Lecommandoux, S. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.05.008 · Cited by 92
Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice
Moreno, D., Zalba, S., Navarro-Blasco, Í., de Ilarduya, C. T., & Garrido, M. J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.10.005 · Cited by 90
Chang, L., Deng, L., Wang, W., Lv, Z., Hu, F., Dong, A., & Zhang, J. (2012) · Biomacromolecules · doi:10.1021/bm301086c · Cited by 88
Dienst, A., Grunow, A., Unruh, M., Rabausch, B., Nor, J. E., Fries, J. W. U., & Gottstein, C. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji130 · Cited by 87
Demirgöz, D., Pangburn, T. O., Davis, K. P., Lee, S., Bates, F. S., & Kokkoli, E. (2009) · Soft Matter · doi:10.1039/b814217c · Cited by 84
Yadav, A. K., Agarwal, A., Rai, G., Mishra, P., Jain, S., Mishra, A. K., Agrawal, H., & Agrawal, G. P. (2010) · Drug Delivery · doi:10.3109/10717544.2010.500635 · Cited by 77
Vega, J., Ke, S., Fan, Z., et al. (2003) · Pharmaceutical Research · doi:10.1023/a:1023454107190 · Cited by 77
Hou, Z., Zhan, C., Jiang, Q., Hu, Q., Li, L., Chang, D., Yang, X., Wang, Y., Li, Y., Ye, S., et al. (2011) · Nanoscale Research Letters · doi:10.1186/1556-276x-6-563 · Cited by 75
Jin, X., Mo, R., Ding, Y., Zheng, W., & Zhang, C. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400340k · Cited by 74
Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery
Zhang, H., Li, X., Gao, F., Liu, L., Zhou, Z., & Zhang, Q. (2009) · Drug Delivery · doi:10.3109/10717540903508979 · Cited by 73
Christie, R. J., Nishiyama, N., & Kataoka, K. (2009) · Endocrinology · doi:10.1210/en.2009-1045 · Cited by 73
Cheng, L., Jin, C., Wen, L., Ding, Q., & Han, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025433 · Cited by 70
Cheng, M., He, B., Wan, T. Y., Zhu, W., Han, J., Zha, B., Chen, H., Fengxiao, Y., Li, Q., Wang, W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047115 · Cited by 70
Dendritic supramolecular assemblies for drug delivery
Morgan, M. T., Carnahan, M. A., Finkelstein, S., Prata, C. A. H., Degoricija, L., Lee, S. J., & Grinstaff, M. W. (2005) · Chemical Communications · doi:10.1039/b502411k · Cited by 69
Liposome targeting to tumors using vitamin and growth factor receptors
Drummond, D. C., Hong, K., Park, J. W., Benz, C. C., & Kirpgtin, D. B. (2000) · Vitamins and hormones · doi:10.1016/s0083-6729(00)60022-5 · Cited by 64
Cheng, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i42.6076 · Cited by 64
Lin, L., & Liu (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32830 · Cited by 62
Effect of binding affinity for siRNA on the in vivo antitumor efficacy of polyplexes
Han, L., Tang, C., & Yin, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.060 · Cited by 57
Amjadi, I., Rabiee, M., Hosseini, M., & Mozafari, M. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9868-4 · Cited by 51
Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells
Papa, A., Basu, S., Sengupta, P., Banerjee, D., Sengupta, S., & Harfouche, R. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-419 · Cited by 51
EGFR Targeted PLGA Nanoparticles Using Gemcitabine for Treatment of Pancreatic Cancer
Aggarwal, S., Yadav, S., & Gupta, S. (2011) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2011.1238 · Cited by 48
Wang, J. L., Tang, G., Shen, J., Hu, Q., Xu, F., Wang, Q. Q., Li, Z. H., & Yang, W. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.045 · Cited by 44
Characterization of cisplatin cytotoxicity delivered from PLGA-systems
Moreno, D., de Ilarduya, C. T., Bandrés, E., Buñuales, M., Azcona, M., Garcia-Foncillas, J., & Garrido, M. J. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.006 · Cited by 43
Davis, D. W., Herbst, R. S., & Abbruzzese, J. L. (2007) · CRC Press eBooks · doi:10.1201/9781420004298 · Cited by 38
Bioresorbable Polymersomes for Targeted Delivery of Cisplatin
Petersen, M. A., Hillmyer, M. A., & Kokkoli, E. (2013) · Bioconjugate Chemistry · doi:10.1021/bc3003259 · Cited by 37
Yordanov, G. G., Skrobanska, R., & Evangelatov, A. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.11.029 · Cited by 34
Targeting of vasculature in cancer and other angiogenic diseases
Kumar, S., & Li, C. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01840-8 · Cited by 31
Cavalli, R., Bisazza, A., Bussano, R., Trotta, M., Civra, A., Lembo, D., Ranucci, E., & Ferruti, P. (2011) · Journal of Drug Delivery · doi:10.1155/2011/587604 · Cited by 31
Kim, S. H., Hyeon, L. S., Tian, H., Chen, X., & Park, T. G. (2009) · Journal of drug targeting · doi:10.1080/10611860902767232 · Cited by 22
Renoir, J., Stella, B., Ameller, T., Connault, E., Opolon, P., & Marsaud, V. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.001 · Cited by 20
Pérez, E., Benito, M., Teijón, C., Olmo, R., Teijón, J. M., & Blanco, M. D. (2012) · Journal of Microencapsulation · doi:10.3109/02652048.2011.651496 · Cited by 15
Maxwell, P. H., & Ashcroft, M. A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605032 · Cited by 14
Cited by
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Kalyane, D., Raval, N., Maheshwari, R., Tambe, V., Kalia, K., & Tekade, R. K. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.01.066 · Cited by 849
Abbasi, R., Shineh, G., Mobaraki, M., Doughty, S., & Tayebi, L. (2023) · Journal of Nanoparticle Research · doi:10.1007/s11051-023-05690-w · Cited by 623
Nanoparticles and targeted drug delivery in cancer therapy
Bahrami, B., Hojjat-Farsangi, M., Mohammadi, H., Anvari, E., Ghalamfarsa, G., Yousefi, M., & Jadidi-Niaragh, F. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.07.015 · Cited by 510
Nanocarriers for drug delivery applications
Chamundeeswari, M., Jeslin, J., & Verma, M. L. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-018-00841-1 · Cited by 444
Metadata
- Authors
- Joshi, M. D., Patravale, V., & Prabhu, R.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2015-02
- Volume
- 10
- Pages
- 1001
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2035910980
- Cited by
- 438
- References
- 141
- FWCI
- 17.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.